ALX Oncology
Emmanuel Ang is a seasoned professional in clinical trial management with extensive experience spanning over two decades in the biotechnology and pharmaceutical sectors. Currently serving as a Senior Clinical Trial Manager at ALX Oncology since February 2022, Emmanuel has previously held significant roles at Alector and Myovant Sciences as a Clinical Trial Manager, enhancing expertise in trial oversight and execution. Emmanuel's career at Gilead Sciences involved various positions from Clinical Project Assistant to Senior Clinical Trial Management Associate, demonstrating a comprehensive skill set in clinical research. Earlier experience includes roles at Quark Pharmaceuticals Inc. and Elan. Emmanuel holds a certificate in Clinical Trial Design and Management from San Francisco State University and possesses an educational background from the University of California, Davis.
ALX Oncology
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.